Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kavanagh

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
Nature Structural & Molecular Biology|February 15, 2011
Structural basis for engagement by complement factor H of C3b on a self surfaceHugh P Morgan, Christoph Q Schmidt, Mara Guariento, et al.
Molecular Immunology|August 25, 2014
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)Rachael Watson, Emma Wearmouth, Amy-Claire McLoughlin, et al.
Blood|June 27, 2023
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort studyVicky Brocklebank, Patrick R Walsh, Kate Smith-Jackson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activityAnna M Blom, Frida Bergström, Matthew Edey, et al.
Molecular Immunology|April 7, 2015
Atypical aHUS: State of the artCarla M Nester, Thomas Barbour, Santiago Rodriquez de Cordoba, et al.
Stem Cells Translational Medicine|August 21, 2020
Complement modulation reverses pathology in Y402H-retinal pigment epithelium cell model of age-related macular degeneration by restoring lysosomal functionEdvinas Cerniauskas, Marzena Kurzawa-Akanbi, Long Xie, et al.
Frontiers in Immunology|January 16, 2023
A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative <i>CFI</i> variants in age-related macular degenerationThomas M Hallam, Thomas E Cox, Kate Smith-Jackson, et al.
The Journal of Molecular Diagnostics : JMD|April 10, 2022
Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted SequencingNikolai Tschernoster, Florian Erger, Patrick R Walsh, et al.
Kidney International|December 20, 2016
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceTimothy H J Goodship, H Terence Cook, Fadi Fakhouri, et al.
The Lancet Regional Health. Europe|January 19, 2026
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trialAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
Nature Structural & Molecular Biology|February 15, 2011
Structural basis for engagement by complement factor H of C3b on a self surfaceHugh P Morgan, Christoph Q Schmidt, Mara Guariento, et al.
Molecular Immunology|August 25, 2014
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)Rachael Watson, Emma Wearmouth, Amy-Claire McLoughlin, et al.
Blood|June 27, 2023
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort studyVicky Brocklebank, Patrick R Walsh, Kate Smith-Jackson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activityAnna M Blom, Frida Bergström, Matthew Edey, et al.
Molecular Immunology|April 7, 2015
Atypical aHUS: State of the artCarla M Nester, Thomas Barbour, Santiago Rodriquez de Cordoba, et al.
Stem Cells Translational Medicine|August 21, 2020
Complement modulation reverses pathology in Y402H-retinal pigment epithelium cell model of age-related macular degeneration by restoring lysosomal functionEdvinas Cerniauskas, Marzena Kurzawa-Akanbi, Long Xie, et al.
Frontiers in Immunology|January 16, 2023
A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative <i>CFI</i> variants in age-related macular degenerationThomas M Hallam, Thomas E Cox, Kate Smith-Jackson, et al.
The Journal of Molecular Diagnostics : JMD|April 10, 2022
Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted SequencingNikolai Tschernoster, Florian Erger, Patrick R Walsh, et al.
Kidney International|December 20, 2016
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceTimothy H J Goodship, H Terence Cook, Fadi Fakhouri, et al.
The Lancet Regional Health. Europe|January 19, 2026
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trialAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Pageof 20